药品注册申请号:011559
申请类型:NDA (新药申请)
申请人:ENDO OPERATIONS
申请人全名:ENDO OPERATIONS LTD
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 BREVITAL SODIUM METHOHEXITAL SODIUM INJECTABLE;INJECTION 500MG/VIAL Yes Yes AP 1960/06/27 Approved Prior to Jan 1, 1982 Prescription
002 BREVITAL SODIUM METHOHEXITAL SODIUM INJECTABLE;INJECTION 2.5GM/VIAL Yes No None Approved Prior to Jan 1, 1982 Discontinued
003 BREVITAL SODIUM METHOHEXITAL SODIUM INJECTABLE;INJECTION 5GM/VIAL No No None Approved Prior to Jan 1, 1982 Discontinued
004 BREVITAL SODIUM METHOHEXITAL SODIUM INJECTABLE;INJECTION 200MG/VIAL No No None 2012/12/21 Discontinued
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2020/11/03 SUPPL-57(补充) Approval Labeling STANDARD
2017/04/27 SUPPL-51(补充) Approval Labeling STANDARD
2014/12/15 SUPPL-48(补充) Approval Manufacturing (CMC) STANDARD
2014/09/22 SUPPL-47(补充) Approval Manufacturing (CMC) STANDARD
2014/01/23 SUPPL-45(补充) Approval Labeling STANDARD
2008/05/05 SUPPL-41(补充) Approval Labeling STANDARD
2004/05/27 SUPPL-37(补充) Approval Labeling STANDARD
2003/03/14 SUPPL-33(补充) Approval Manufacturing (CMC) STANDARD
2001/07/13 SUPPL-32(补充) Approval Labeling STANDARD
1998/01/30 SUPPL-29(补充) Approval Efficacy UNKNOWN
1998/01/30 SUPPL-28(补充) Approval Efficacy UNKNOWN
1997/12/17 SUPPL-30(补充) Approval Labeling STANDARD
1996/07/25 SUPPL-27(补充) Approval Manufacturing (CMC) STANDARD
1996/02/29 SUPPL-26(补充) Approval Manufacturing (CMC) STANDARD
1995/11/02 SUPPL-25(补充) Approval Manufacturing (CMC) STANDARD
1994/06/14 SUPPL-24(补充) Approval Manufacturing (CMC) STANDARD
1992/12/18 SUPPL-18(补充) Approval Labeling
1992/12/02 SUPPL-21(补充) Approval Labeling STANDARD
1988/07/08 SUPPL-14(补充) Approval Labeling
1981/07/01 SUPPL-12(补充) Approval Manufacturing (CMC) STANDARD
1979/10/04 SUPPL-10(补充) Approval Manufacturing (CMC) STANDARD
1976/05/14 SUPPL-9(补充) Approval Labeling
1975/06/13 SUPPL-8(补充) Approval Labeling
1969/12/11 SUPPL-4(补充) Approval Labeling
1960/06/27 ORIG-1(原始申请) Approval Type 1 - New Molecular Entity STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:METHOHEXITAL SODIUM 剂型/给药途径:INJECTABLE;INJECTION 规格:500MG/VIAL 治疗等效代码:AP
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
011559 001 NDA BREVITAL SODIUM METHOHEXITAL SODIUM INJECTABLE;INJECTION 500MG/VIAL Prescription Yes Yes AP Approved Prior to Jan 1, 1982 ENDO OPERATIONS
215488 001 ANDA METHOHEXITAL SODIUM METHOHEXITAL SODIUM INJECTABLE;INJECTION 500MG/VIAL Prescription No No AP 2024/10/03 STERISCIENCE SPECLTS
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database